Ixekizumab vs. guselkumab in plaque psoriasis, Blauvelt et al

Sdílet
Vložit
  • čas přidán 20. 06. 2021
  • Author video for 'A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial'
    Full article: doi.org/10.1111/bjd.19509
  • Věda a technologie

Komentáře •